Deborah Day Barbara
Nessuna posizione attualmente
Profilo
Deborah Day Barbara's former jobs include Director-Business & Technology Development at The Johns Hopkins University, Vice President-Business Development at Standard Diversified, Inc., and Vice President-Business Development & Licensing at Ore Pharmaceuticals, Inc. She also served as Vice President-Strategy & Business Development at Maravai Lifesciences Holdings, Inc. from 2022 to 2023.
Ms. Barbara holds an MBA from Loyola University Maryland, Inc. and an undergraduate degree from the University of Maryland.
Precedenti posizioni note di Deborah Day Barbara
Società | Posizione | Fine |
---|---|---|
MARAVAI LIFESCIENCES HOLDINGS, INC. | Corporate Officer/Principal | 01/11/2023 |
Ore Pharmaceuticals, Inc.
Ore Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ore Pharmaceuticals, Inc. operates as a drug development company, which developed drug candidates for therapeutic uses. The firm marketed its drug repositioning capabilities to pharmaceutical companies based in North America, Japan and Europe. The company was founded in September 1994 and was headquartered in Wellesley, MA. | Corporate Officer/Principal | - |
The Johns Hopkins University | Corporate Officer/Principal | - |
STANDARD DIVERSIFIED INC | Corporate Officer/Principal | - |
Formazione di Deborah Day Barbara
Loyola University Maryland, Inc. | Masters Business Admin |
University of Maryland | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
MARAVAI LIFESCIENCES HOLDINGS, INC. | Health Technology |
Aziende private | 2 |
---|---|
Standard Diversified, Inc.
Standard Diversified, Inc. TobaccoConsumer Non-Durables Standard Diversified, Inc. is a holding company, which owns and operates subsidiaries in a variety of industries, including other tobacco products, insurance, and outdoor advertising. It operates through the following segments: Smokeless Products, Smoking Products, and NewGen Products. The Smokeless Product segment manufactures and markets moist snuff and contracts for and markets chewing tobacco products. The Smoking Products segment imports and markets cigarette papers, tubes, and related products; imports and markets finished cigars, MYO cigar tobaccos, and cigar wraps; and processes, packages, and markets pipe tobaccos. The NewGen Products segment trades e-cigarettes, e-liquids, vaporizers, and other related products; and distributes a wide assortment of vaping products to non-traditional retail outlets via VaporBeast and Vapor Shark. The company was founded by Martha C. Reider, Anne Cavanaugh and Richard C. Birkmeyer in 1990 and is headquartered in New York, NY. | Consumer Non-Durables |
Ore Pharmaceuticals, Inc.
Ore Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ore Pharmaceuticals, Inc. operates as a drug development company, which developed drug candidates for therapeutic uses. The firm marketed its drug repositioning capabilities to pharmaceutical companies based in North America, Japan and Europe. The company was founded in September 1994 and was headquartered in Wellesley, MA. | Health Technology |
- Borsa valori
- Insiders
- Deborah Day Barbara